THZ2

≥99%

  • Product Code: 102921
  CAS:    1604810-84-5
Molecular Weight: 566.05 g./mol Molecular Formula: C₃₁H₂₈ClN₇O₂
EC Number: MDL Number:
Melting Point: Boiling Point:
Density: Storage Condition: 2-8℃
Product Description: THZ2 is primarily used in cancer research as a potent and selective inhibitor of CDK7, a cyclin-dependent kinase involved in cell cycle regulation and transcription. It is particularly studied for its potential in targeting cancers driven by transcriptional dysregulation, such as triple-negative breast cancer and small cell lung cancer. By inhibiting CDK7, THZ2 disrupts the transcription of key oncogenes, leading to cancer cell death. Its application extends to preclinical studies where it helps in understanding the role of CDK7 in tumorigenesis and evaluating its efficacy as a therapeutic target. THZ2 is also utilized in combination therapies to enhance the effectiveness of other anticancer agents.
Sizes / Availability / Pricing:
Size (g) Availability Price Quantity
0.005 10-20 days $1,700.55
+
-
0.010 10-20 days $2,525.06
+
-
THZ2
THZ2 is primarily used in cancer research as a potent and selective inhibitor of CDK7, a cyclin-dependent kinase involved in cell cycle regulation and transcription. It is particularly studied for its potential in targeting cancers driven by transcriptional dysregulation, such as triple-negative breast cancer and small cell lung cancer. By inhibiting CDK7, THZ2 disrupts the transcription of key oncogenes, leading to cancer cell death. Its application extends to preclinical studies where it helps in understanding the role of CDK7 in tumorigenesis and evaluating its efficacy as a therapeutic target. THZ2 is also utilized in combination therapies to enhance the effectiveness of other anticancer agents.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Cart

No products

Subtotal: $0.00
$0.00 Total :